Editorial: Metabolomic analysis of breath volatile organic compounds - A new scent for inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 6, 2014, Pages 732-733

  Arasaradnam, R P ^a   Covington, J ^b   Nwokolo, C U ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 DECENE; 1 OCTENE; 2 NONENE; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND;

BREATH ANALYSIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE MARKER; EDITORIAL; HUMAN; INFLAMMATORY BOWEL DISEASE; ION MONITORING; MASS SPECTROMETRY; MEASUREMENT PRECISION; METABOLOMICS; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SELECTED ION FLOW TUBE MASS SPECTROSCOPY;

ALKENES; COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; VOLATILE ORGANIC COMPOUNDS;

EID: 84906088673     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12901     Document Type: Editorial

References (6)

1. Patel N, Alkhouri N, Eng K, et al,. Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther 2014; 40: 498-507.
2. Cao W, Duan Y,. Current status of methods and techniques for breath analysis. Crit Rev Anal Chem 2007; 37: 3-13.
3. Kokoszka J, Nelson RL, Swedler WI, et al,. Determination of inflammatory bowel disease activity by breath pentane analysis. Dis Colon Rectum 1993; 36: 597-601.
4. Pelli MA, Trovarellu G, Capodicasa E, et al,. Breath alkanes determination in ulcerative colitis and Crohn's disease. Dis Colon Rectum 1999; 42: 71-6.
5. Rampersad G, Suck G, Sakac D, et al,. Chemical compounds that target thiol-disulphide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cells. Transfusion 2005; 45: 384-93.
6. Arasaradnam RP, Covington JA, Harmston C, Nwokolo CU,. Review article: next generation diagnostic modalities in gastroenterology-gas phase volatile compound biomarker detection. Alimentary Pharmacology & Therapeutics 2014; 39: 780-789.